
Articles of note for people dealing with pituitary disease and related conditions.

The latest from pharmaceutical companies and healthcare organizations

Brief, insightful commentary from Dr. Lewis Blevins on issues of relevance to pituitary disease.
From Discovery to Delivery: Crinetics Co-Founders on the Journey to Bring new drugs to Patients
In today’s podcast, Crinetics co-founders Dr. Scott Struthers and Dr. Steve Betz share their views and experiences in drug discovery and development, revealing what it really takes to bring a new medication from concept to patients.
Is Your Pituitary Tumor Genetic? Key Signs and Testing Guidelines
We’re delighted to share this article by Dr. Jennifer Perkins on genetics and pituitary disease, a subject of great interest to our community. If you follow our work, you know we’ve published extensively on this
Worth noting:
Recordati announces FDA approval of ISTURISA® new indication in the U.S. to treat endogenous hypercortisolemia in patients with Cushing’s syndrome,- Learn more here
Corcept Therapeutics announces FDA Relacolirant new drug application to treat Hypercortisolism . Read more
From Crinetics Pharmaceuticals – FDA accepts Crinetics new drug Paltusotine’s application for adults with acromegaly . Read more
Camurus announces final results for the once-monthly octreotide subcutaneous treatment option for acromegaly. Read more
New support site from Chiesi; Rethink acromegaly
Pfizer announces Together with Acromegaly patient support site and Together for Rare: Understanding your insurance options video.
Chiesi relaunches a patient-facing website for Mycapssa.

Content for physicians and healthcare professionals.
Join a drug trial. Find out how. Here’s a partial list of studies.

Latest trends and a roundup of health and wellness news
Latest Videos
The Podcast
Knowledge and information are critical tools to affect early diagnosis in pituitary disease. Join Dr. Lewis Blevins and Jorge D. Faccinetti cofounders, as they navigate the wonders and complexities of pituitary conditions.
Live Talk on Demand
In the latest episode of the Pituitary World News podcast, Jorge D. Faccinetti sits down with Dr. Markus Johnsson, Senior VP of R&D at Camurus, to explore the fascinating world of FluidCrystal® technology. This innovative approach promises to revolutionize the way we think about drug delivery, providing long-lasting solutions for chronic diseases particularly for people with acromegaly.





















